scholarly journals Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?

Author(s):  
Aaron P. Mitchell ◽  
Niti U. Trivedi ◽  
Renee L. Gennarelli ◽  
Susan Chimonas ◽  
Sara M. Tabatabai ◽  
...  
2016 ◽  
Vol 176 (8) ◽  
pp. 1114 ◽  
Author(s):  
Colette DeJong ◽  
Thomas Aguilar ◽  
Chien-Wen Tseng ◽  
Grace A. Lin ◽  
W. John Boscardin ◽  
...  

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Parth Modi ◽  
Matthew Ingham ◽  
Eric Singer ◽  
Steven Chang

1988 ◽  
Vol 18 (4) ◽  
pp. 603-616 ◽  
Author(s):  
Joel Lexchin

The Canadian medical profession has a long history of allying itself with the Canadian pharmaceutical industry. This alliance exists on two levels: medical associations and medical journals. As a result of the alliance the traditional emphasis of the medical profession on the primacy of the welfare of the patient has been subverted in favor of the profit motive of the drug industry. Elements of the medical profession promote useless pharmaceutical research, poor physician prescribing, and physician involvement in educational activities controlled by the industry. Specific reforms to loosen the alliance are outlined, but ultimately the alliance will only be broken when the values of Canadian physicians change.


2016 ◽  
Vol 22 (2) ◽  
Author(s):  
Peter J. Pitts

Much ado about pharma freebies to physicians. Much ado about nothing medically and everything politically. A new study published by JAMA Internal Medicine (Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries)makes it sound (as Meagan McArdle has written for Bloomberg), that your doctor is “willing to sell you out for the price of a sandwich.” It’s not that simple … or true.A valuable takeaway from the new JAMA study should be that wide adoption of Open Payments reporting has led to transparent interactions and value exchanges of education, money and meals between the pharmaceutical industry and prescribers. These data are now available to inform and improve educational efforts to meet the treatment needs of patients using the latest advances in medicine and science. However, such data must be cautiously interpreted with full acknowledgement of study limitations and author bias. 


1992 ◽  
Vol 22 (2) ◽  
pp. 331-338 ◽  
Author(s):  
T. Shawn Caudill ◽  
Nicole Lurie ◽  
Eugene C. Rich

2016 ◽  
Vol 2 (4) ◽  
pp. 234-241
Author(s):  
Mohammed Al-Shakka ◽  
Ebtesam Abood ◽  
Adel Al-Dhubhany ◽  
Sami Abdo Radman Aldubai ◽  
Khaled Said ◽  
...  

Because of the almost-instant connection with the welfare and well-being of individuals, pharmaceutical industry stands prominently as a very important factor for the improvement and progress of a healthy productive nation. These days, pharmaceutical industry thrives as one of the largest and exponentially expanding global industries. Nonetheless, millions of people in low income developing countries, have to suffer from the fatal consequences of the inaccessibility and non-availability of essential drugs. This is also happening in Yemen, where the pharmaceutical manufacturers sector have to face up to many challenges. The Yemen Drug Company (YEDCO) was founded in 1964 by the Yemeni government as it collaborated with private investors. It was endorsed as a company with the expertise in the medicinal drug marketing. YEDCO started its work by taking in drugs from foreign companies and then locally marketing and distributing them. In 1982, YEDCO built the first medicinal factory for drugs in Sana’a. Since then, seven companies were set up to manufacture medicines in Yemen. The expanding population has led to the need to have more pharmaceutical products. It may be understandable that pharmaceutical manufacturer companies are also hit by the political crisis in the country. Inadequate amount of fuel and raw material as well as low security status were some of the underlying factors behind these ill-effects in Yemen. Imported drugs make up about nearly 90% % of the pharmaceutical market compared to 10% drugs from the domestic market. This situation has led to an additional burden being shouldered by the national economy, where Yemen spends about US$263 million annually on pharmaceutical drugs, in reference to the national Supreme Drugs Authority. Although there is a very quick growth in the population and drugs consumption, the pharmaceutical industry has not been very active, where global pharmaceutical products play their role dominantly on the domestic market. The pharmaceutical production necessitates skilled human resources like university graduates. By contrast, the government and the private sector should also motivate the pharmaceutical industry and make use of the local employment


Sign in / Sign up

Export Citation Format

Share Document